Arbidol - CAS 131707-25-0
Catalog number: 131707-25-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C22H25BrN2O3S
Molecular Weight:
477.43
COA:
Inquire
Targets:
Others
Description:
Arbidol is an antiviral agent using for the treatment of influenza infection in Russia and China. It inhibits membrane fusion and prevents contact between the virus and target host cells. Fusion between the viral capsid and the cell membrane of the target cell is inhibited and this prevents viral entry to the target cell. Although some Russian studies have shown it to be effective, it is not approved for use in Western countries.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
White to off-white crystalline powder
Synonyms:
Umifenovir;ethyl 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
influenza infection
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Boiling Point:
591.8ºC at 760 mmHg
Density:
1.37 g/cm3
InChIKey:
KCFYEAOKVJSACF-UHFFFAOYSA-N
InChI:
InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3
Canonical SMILES:
CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3
1.The cytokine storm of severe influenza and development of immunomodulatory therapy.
Liu Q1, Zhou YH1, Yang ZQ2. Cell Mol Immunol. 2016 Jan;13(1):3-10. doi: 10.1038/cmi.2015.74. Epub 2015 Jul 20.
Severe influenza remains unusual in its virulence for humans. Complications or ultimately death arising from these infections are often associated with hyperinduction of proinflammatory cytokine production, which is also known as 'cytokine storm'. For this disease, it has been proposed that immunomodulatory therapy may improve the outcome, with or without the combination of antiviral agents. Here, we review the current literature on how various effectors of the immune system initiate the cytokine storm and exacerbate pathological damage in hosts. We also review some of the current immunomodulatory strategies for the treatment of cytokine storms in severe influenza, including corticosteroids, peroxisome proliferator-activated receptor agonists, sphingosine-1-phosphate receptor 1 agonists, cyclooxygenase-2 inhibitors, antioxidants, anti-tumour-necrosis factor therapy, intravenous immunoglobulin therapy, statins, arbidol, herbs, and other potential therapeutic strategies.
2.The Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study.
Galiano V1, Villalaín J2. J Membr Biol. 2016 Feb 3. [Epub ahead of print]
Arbidol is a potent broad-spectrum antiviral molecule for the treatment and prophylaxis of many viral infections. Viruses that can be inhibited by arbidol include enveloped and non-enveloped viruses, RNA and DNA viruses, as well as pH-independent and pH-dependent ones. These differences in viral types highlight the broad spectrum of Arb antiviral activity and, therefore, it must affect a common viral critical step. Arbidol incorporates rapidly into biological membranes, and some of its antiviral effects might be related to its capacity to interact with and locate into the membrane. However, no information is available of the molecular basis of its antiviral mechanism/s. We have aimed to locate the protonated (Arp) and unprotonated (Arb) forms of arbidol in a model membrane system. Both Arb and Arp locate in between the hydrocarbon acyl chains of the phospholipids but its specific location and molecular interactions differ from each other.
3.Towards antivirals against chikungunya virus.
Abdelnabi R1, Neyts J2, Delang L1. Antiviral Res. 2015 Sep;121:59-68. doi: 10.1016/j.antiviral.2015.06.017. Epub 2015 Jun 25.
Chikungunya virus (CHIKV) has re-emerged in recent decades, causing major outbreaks of chikungunya fever in many parts of Africa and Asia, and since the end of 2013 also in Central and South America. Infections are usually associated with a low mortality rate, but can proceed into a painful chronic stage, during which patients may suffer from polyarthralgia and joint stiffness for weeks and even several years. There are no vaccines or antiviral drugs available for the prevention or treatment of CHIKV infections. Current therapy therefore consists solely of the administration of analgesics, antipyretics and anti-inflammatory agents to relieve symptoms. We here review molecules that have been reported to inhibit CHIKV replication, either as direct-acting antivirals, host-targeting drugs or those that act via a yet unknown mechanism. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World."
4.Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.
Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. J Prev Med Hyg. 2014 Sep;55(3):69-85.
Influenza is a contagious respiratory acute viral disease characterized by a short incubation period, high fever and respiratory and systemic symptoms. The burden of influenza is very heavy. Indeed, the World Health Organization (WHO) estimates that annual epidemics affect 5-15% of the world's population, causing up to 4-5 million severe cases and from 250,000 to 500,000 deaths. In order to design anti-influenza molecules and compounds, it is important to understand the complex replication cycle of the influenza virus. Replication is achieved through various stages. First, the virus must engage the sialic acid receptors present on the free surface of the cells of the respiratory tract. The virus can then enter the cells by different routes (clathrin-mediated endocytosis or CME, caveolae-dependent endocytosis or CDE, clathrin-caveolae-independent endocytosis, or macropinocytosis). CME is the most usual pathway; the virus is internalized into an endosomal compartment, from which it must emerge in order to release its nucleic acid into the cytosol.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


LY 249933
(CAS: 123250-77-1)

LY 249933 is a bio-active molecular under the development of Eli Lilly. It has positive inotropic activity as a cardioselective 1,4-dihydropyridine compound.

CAS 104206-65-7 Nitisinone

Nitisinone
(CAS: 104206-65-7)

Nitisinone(SC0735) is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase.

CAS 5915-41-3 Terbuthylazine

Terbuthylazine
(CAS: 5915-41-3)

Terbuthylazine is a triazine herbicide.

OTS-514
(CAS: 1338540-63-8)

OTS-514, a quinolone derivative, is an effective TOPK inhibitor and has been found to have potential effect against Renal cancer. It is still under preclinical ...

CAS 20784-50-3 Isobavachalcone

Isobavachalcone
(CAS: 20784-50-3)

Neuroblastoma, the most common solid extracranial neoplasm in children, originates from embryonic neural crest cells that usually form the sympathetic ganglia a...

Hybendazole hydrochloride
(CAS: 37975-24-9)

Hybendazole hydrochloride is a synthetic bio-active chemical.

CAS 79350-37-1 Cefixime

Cefixime
(CAS: 79350-37-1)

Cefixime is an effective, orally active and a third generation cephalosporin antibiotic. It is useful for the treatment of a number of bacterial infections, suc...

CAS 61303-13-7 Isoacteoside

Isoacteoside
(CAS: 61303-13-7)

Isoacteoside is a natural compound which exhibit significant inhibition of advanced glycation end product formation, compared with those of aminoguanidine and q...

CAS 86-34-0 phensuximide

phensuximide
(CAS: 86-34-0)

Phensuximide is an anticonvulsant drug. It can be used for the treatment of neurological disorders stemming from the brain. Phensuximide can suppress the paroxy...

CAS 9005-49-6 Heparin

Heparin
(CAS: 9005-49-6)

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological...

CAS 1035979-44-2 P005672 HCl

P005672 HCl
(CAS: 1035979-44-2)

P005672 HCl is a novel, tetracycline-substituted, narrow-spectrum antibiotic compound used for treatment of bacterial infections and neoplasms. It is developed ...

GI 181771
(CAS: 305366-98-7)

GI-181771X is a novel effect of oral CCK-1 agonist on fasting and postprandial gastric functions in healthy volunteers.

BMS-247243
(CAS: 307316-55-8)

BMS-247243 is a novel β-Lactamase inhibitor which is a family of enzymes involved in bacterial resistance to beta-lactam antibiotics.

CAS 478-01-3 Nobiletin

Nobiletin
(CAS: 478-01-3)

Nobiletin, a citrus flavonoid isolated from citrus peels like in tangerine, which has anti-inflammatory and anti-tumor activities.

Sonoflora 1
(CAS: 1609250-37-4)

Sonoflora 1, a kind of PDT photosensitivizer, was once studied against breast cancer and the Phase I/II trial has been already discontinued by SonneMed.

CAS 1448693-69-3 A-92

A-92
(CAS: 1448693-69-3)

A-92 inhibits the stress response of general control nonderepressible 2 kinase (GCN2 or EIF2AK4) (IC50 value of <0.3 μM). It is potentially used as a chemothera...

CAS 87626-56-0 LM985

LM985
(CAS: 87626-56-0)

LM985, the diethylaminoester derivative of LM975, has anti-tumor activities.

CAS 19309-14-9 Cardamonin

Cardamonin
(CAS: 19309-14-9)

Cardamonin is a naturally occuring chalcone initially isolated from the seeds of Amomum subulatum and subsequently from other zingiberous plant species. Cardamo...

CAS 11088-09-8 Wilforine

Wilforine
(CAS: 11088-09-8)

Wilforine, a sesquiterpene pyridine alkaloid, is effective in treating idiopathic pulmonary fibrosis.

CAS 1009816-48-1 Thiamet G

Thiamet G
(CAS: 1009816-48-1)

Thiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37,000-fold selectivity over human lysosomal –hexosaminidase.

Chemical Structure

CAS 131707-25-0 Arbidol

Quick Inquiry

Verification code

Featured Items